Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer

18 Nov 2020

Abstract excerpt

No consensus currently exist on the optimal treatment of patients with high-risk nonmuscle invasive (HGT1) micropapillary variant of bladder cancer (MPBC). Transcripsome analysis may allow stratification of MPBC-HGT1 enabling prediction of recurrence and guide therapeutic management for individual patients. Whole transcriptome RNA-Sequencing of tumors from 23 patients with MPBC-HGT1 and 64 conventional urothelial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Epigenetics and DNA Methylation
Share to Urinary and Genital Oncology Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33208770
DOI: 10.1038/s41598-020-76904-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancerPMID 33208770Read ↗

Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder Cancer.Semantic proximity Read ↗

Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight.Semantic proximity Read ↗

Transcriptomic Profiling of Upper Tract Urothelial Carcinoma: Bladder Cancer Consensus Classification Relevance, Molecular Heterogeneity, and Differential Immune SignaturesSemantic proximity Read ↗

Development of a Multiplex Quantitative PCR Signature to Predict Progression in Non–Muscle-Invasive Bladder CancerSemantic proximity Read ↗

An EMT‐related gene signature for the prognosis of human bladder cancerSemantic proximity Read ↗

Combined exome and transcriptome sequencing of non-muscle-invasive bladder cancer: associations between genomic changes, expression subtypes, and clinical outcomesSemantic proximity Read ↗

Histologic variants in bladder cancer harbor aggressive molecular features including TM4SF1 expression and a CA125+ cell stateSemantic proximity Read ↗

Epigenomic analysis of high-grade T1 bladder cancer reveals subtypes with clinical implications that display extensive intra-tumor heterogeneity with spatial features.Semantic proximity Read ↗

Epigenetic Subtypes of High-Grade T1 Bladder Cancer Reveal Intra-Tumor Heterogeneity and Distinct Interactions with Tumor MicroenvironmentSemantic proximity Read ↗

Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial CarcinomaSemantic proximity Read ↗

Biological determinants of bladder cancer gene expression subtypesSemantic proximity Read ↗

A Molecular Taxonomy for Urothelial CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.